InvestorsHub Logo
Followers 0
Posts 16
Boards Moderated 0
Alias Born 02/26/2012

Re: Bob_the_Trader post# 21216

Thursday, 09/04/2014 7:35:39 PM

Thursday, September 04, 2014 7:35:39 PM

Post# of 48316
You hit the nail on the head Bob, Oncosec couldn't afford to go ahead with the combinational pd1 trial until a pd1 was approved. Now things are really getting interesting with this approval, and who was that Doctor that was in charge of a 20 member research team for Merck's pd1 drug. Shareholders who were run off in the .40s and now selling in the .50s will probably be regretting it possibly very soon.